Merck: The A.I.R. Program - Singulair

Merck & Co., Inc., in marketing its asthma controller medication Singulair, needed to counter the fact that most people stopped taking their asthma medication after a few months because they felt better and, when necessary, used an inhaler for temporary relief.

Merck: The A.I.R. Program - Singulair

MicroMass Communications


Category: Pharmaceutical/HealthcareCountry where program ran: USADate program started/ended: Ongoing from October 2007

Product Description: Singulair® is an asthma controller medication. The A.I.R. Program is Singulair's behavioral science-based DM campaign for patients and caregivers; it teaches the importance of continuing to take Singulair as prescribed. We designed the program to counter the fact that most patients stop taking their asthma controllers after a few months.

Advertiser/Client Name: Merck & Co., Inc.Media Channels: Direct Mail Email Website:



Not a subscriber?

Schedule your live demo with our team today

WARC helps you to plan, create and deliver more effective marketing

  • Prove your case and back-up your idea

  • Get expert guidance on strategic challenges

  • Tackle current and emerging marketing themes

We’re long-term subscribers to WARC and it’s a tool we use extensively. We use it to source case studies and best practice for the purposes of internal training, as well as for putting persuasive cases to clients. In compiling a recent case for long-term, sustained investment in brand, we were able to support key marketing principles with numerous case studies sourced from WARC. It helped bring what could have been a relatively dry deck to life with recognisable brand successes from across a broad number of categories. It’s incredibly efficient to have such a wealth of insight in one place.

Insights Team
Bray Leino

You’re in good company

We work with 80% of Forbes' most valuable brands* and 80% of the world's top top-of-the-class agencies.

* Top 10 brands